1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Issue 12 (December 2021) Authors: Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San-Miguel, Jesus; Avet-Loiseau, Hervé; Mohty, Mohamad; Mateos, Maria-Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Melitios A; Gay, Francesca; Ein... Journal: Lancet Issue: Volume 8:Issue 12(2021) Page Start: e934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deacetylase inhibitors as a novel modality in the treatment of multiple myeloma. (March 2017) Authors: Richardson, Paul G.; Moreau, Philippe; Laubach, Jacob P.; Maglio, Michelle E.; Lonial, Sagar; San-Miguel, Jesus Journal: Pharmacological research Issue: Volume 117(2017:Mar.) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR. Issue 10 (1st April 2021) Authors: Avet-Loiseau, Hervé; San-Miguel, Jesus; Casneuf, Tineke; Iida, Shinsuke; Lonial, Sagar; Usmani, Saad Z.; Spencer, Andrew; Moreau, Philippe; Plesner, Torben; Weisel, Katja; Ukropec, Jon; Chiu, Christopher; Trivedi, Sonali; Amin, Himal; Krevvata, Maria; Ramaswami, Priya; Qin, Xiang; Qi, Mia; Sun, S... Journal: Journal of clinical oncology Issue: Volume 39:Issue 10(2021) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HOW TO INCORPORATE MRD IN CLINICAL TRIALS. (5th April 2022) Authors: San-Miguel, Jesus Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. Issue 10214 (7th December 2019) Authors: Attal, Michel; Richardson, Paul G; Rajkumar, S Vincent; San-Miguel, Jesus; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A; Huang, Jeffrey Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H Miles; Macé, Sandrine; Corzo, Kathryn P; Campana, ... Journal: Lancet Issue: Volume 394:Issue 10214(2019) Page Start: 2096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study. Issue 3 (March 2022) Authors: Richardson, Paul G; Perrot, Aurore; San-Miguel, Jesus; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A; Huang, Jeffrey Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H Miles; Malinge, Laure; Dubin, Franck; van de Velde, Helgi; Anderson, K... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. Issue 10218 (11th January 2020) Authors: Mateos, Maria-Victoria; Cavo, Michele; Blade, Joan; Dimopoulos, Meletios A; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yo... Journal: Lancet Issue: Volume 395:Issue 10218(2019) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗